|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 28 February 2022, 9:24. The announcement is marked as price sensitive, and is 3 page(s) in length and 300.56kb in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.002% short sold according to ASIC data. It was ranked the 680th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| DSMB Change to REMAP-CAP COVID-19 Study | 28 February 2022, 9:24 |
| Investor Presentation | 24 February 2022, 9:57 |
| Half-Year Financial Report & Appendix 4D - 31 December 2021 | 24 February 2022, 9:24 |
| Dimerix Appoints Chief Medical Officer | 7 February 2022, 10:46 |
You must be logged in to post a reply.
Dimerix 